Press Releases Xvivo Perfusion AB

Equities

XVIVO

SE0004840718

Market Closed - Nasdaq Stockholm Other stock markets 11:29:49 2024-04-29 am EDT			5-day change	1st Jan Change
377 ^SEK	+1.07%		+20.06%	+14.42%

Apr. 24	Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest	DJ
Apr. 24	Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)	Apr. 25	AQ
Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.	Apr. 19	AQ
Xvivo Perfusion : Results from XVIVO's clinical trial NIHP2019 for heart preservation presented at ISHLT in Prague	Apr. 11	PU
Results from XVIVO’s clinical trial NIHP2019 for heart preservation presented at ISHLT in Prague	Apr. 11	AQ
Xvivo Perfusion : Notice to AGM 2024	Mar. 21	PU
Xvivo Perfusion : SORP 2024	Mar. 21	PU
Xvivo Perfusion : Styrelsens 19-22 redogörelse (Eng)	Mar. 21	PU
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN XVIVO PERFUSION AB (PUBL)	Mar. 21	AQ
The first-ever transplantation with a donor heart transported across the Atlantic Ocean – made possible by the use of XVIVO’s heart technology	Feb. 29	AQ
XVIVO presents Report on Operations 2023	Jan. 25	AQ
XVIVO reaches milestone in Italy: 1,200 lifesaving perfusions performed with Liver Assist	Dec. 22	AQ
XVIVO announces a write-down related to PrimECC of SEK 17 million not affecting cashflow or EBITDA	Dec. 14	AQ
Results from a Australian/New Zealand study using XVIVO’s heart technology published	Nov. 03	AQ
Xvivo Perfusion : Interim ReportQ32023	23-10-24	PU
Leading acacemic medical center performs first heart transplant in the U.S. utilizing NIHP technology as part of XVIVO's PRESERVE clinical trial	23-10-23	AQ
Increased number of shares and votes in XVIVO Perfusion AB (publ)	23-10-02	AQ
Increased number of shares and votes in XVIVO Perfusion AB (publ)	23-09-29	AQ
Nomination committee of XVIVO Perfusion AB (publ)	23-09-29	AQ
XVIVO has carried out a directed share issue of 1,600,000 shares at a subscription price of SEK 275 per share, raising gross proceeds of SEK 440 million	23-09-13	AQ
XVIVO intends to carry out a directed share issue	23-09-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Xvivo Perfusion AB

Equities

XVIVO

SE0004840718

Press Releases

Filters